NANOG and neoplasm: In the HT1080 flank xenograft model,inhibition of Nanog synergized with doxorubicin to reduce tumor growth, andhistologic examination of treated tumors found dramatic increases in tumor cellapoptosis and depletion of CD133+ cells.